Cargando…
Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713809/ https://www.ncbi.nlm.nih.gov/pubmed/36468046 http://dx.doi.org/10.3389/fneur.2022.1041437 |
_version_ | 1784842092316459008 |
---|---|
author | Damen, Manon J. den Broeder, Alfons A. Voermans, Nicol C. Tieleman, Alide A. |
author_facet | Damen, Manon J. den Broeder, Alfons A. Voermans, Nicol C. Tieleman, Alide A. |
author_sort | Damen, Manon J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9713809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97138092022-12-02 Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 Damen, Manon J. den Broeder, Alfons A. Voermans, Nicol C. Tieleman, Alide A. Front Neurol Neurology Frontiers Media S.A. 2022-11-17 /pmc/articles/PMC9713809/ /pubmed/36468046 http://dx.doi.org/10.3389/fneur.2022.1041437 Text en Copyright © 2022 Damen, den Broeder, Voermans and Tieleman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Damen, Manon J. den Broeder, Alfons A. Voermans, Nicol C. Tieleman, Alide A. Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 |
title | Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 |
title_full | Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 |
title_fullStr | Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 |
title_full_unstemmed | Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 |
title_short | Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2 |
title_sort | commentary: autoimmune diseases in patients with myotonic dystrophy type 2 |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713809/ https://www.ncbi.nlm.nih.gov/pubmed/36468046 http://dx.doi.org/10.3389/fneur.2022.1041437 |
work_keys_str_mv | AT damenmanonj commentaryautoimmunediseasesinpatientswithmyotonicdystrophytype2 AT denbroederalfonsa commentaryautoimmunediseasesinpatientswithmyotonicdystrophytype2 AT voermansnicolc commentaryautoimmunediseasesinpatientswithmyotonicdystrophytype2 AT tielemanalidea commentaryautoimmunediseasesinpatientswithmyotonicdystrophytype2 |